Table 1.

Characteristics of COVID-19 patient A, B, and C.

Characteristics	Patient A	Patient B	Patient C
Age (years)	35	67	44
Gender	Male	Female	Male
Underlying medical condition	Chronic HBV infection with abnormal liver function	Hypothyroidism, angiosclerotic heart disease	No
Clinical typing	Moderate	Severe	Moderate
Date of illness onset	31-Jan, 2020	25-Jan, 2020	1-Feb, 2020
Day after illness onset on admission	1	5	3
Fever	Yes	Yes	Yes
The highest temperature	38.4°C	38.0°C	38.0°C
Cough	Yes	Yes	No
Expectoration	No	Yes	No
Chest radiograph findings on admission	Bilateral pneumonia, ground-glass opacity	Bilateral pneumonia, multiple mottling, and ground-glass opacity	Bilateral pneumonia, ground-glass opacity in left upper and lower lobe and right middle lobe
Complications
Failure of respiratory function	No	Yes	No
Acute liver damage	Abnormal liver function before illness onset	Yes	Yes
Antiviral therapy	Lopinavir and ritonavir tablets (500 mg bid, started at February 2 till 20), Oseltamivir (started at February 2 till 5)	Lopinavir and ritonavir tablets, arbidol hydrochloride granules, aerosol therapy with α-interferon	Lopinavir and ritonavir tablets, arbidol hydrochloride granules, chloroquine phosphate, aerosol therapy with α-interferon
Antibiotic therapy	Yes	Yes	Yes
Outcome	Recovered	Recovered	Recovered